ArticleEULAR rheumatology open2025
Feasibility of INSELMA: an interdisciplinary nurse-coordinated self-management intervention for people with inflammatory arthritis and substantial disease impact.
Article in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Inflammatory arthritis significantly impacts daily life, requiring interdisciplinary support despite optimal pharmacological treatment. We developed a 6-month interdisciplinary nurse-coordinated self-management intervention (INSELMA) based on the British Medical Research Council's framework for complex interventions. The intervention includes a biopsychosocial assessment, goal setting, and continuous support from the coordinating nurse, with referrals to other healthcare professionals and municipal offers. This study aimed to evaluate the feasibility of the INSELMA intervention. Methods: We conducted a multicentre single-arm pre-test-post-test study. Patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) were recruited via the Danish nationwide Rheumatology registry, DANBIO. Patient-reported outcomes were collected at baseline and end of the intervention. Feasibility was assessed by evaluating recruitment, retention, attendance rates, fidelity, goal setting, activities, resources and data collection methods. Results: A total of 386 patients were screened, 18 were included (8 with RA, 6 with PsA and 4 with AxSpA) and 17 completed the 6-month intervention. The interdisciplinary team allocated an average of 8 hours per participant, with nurses contributing 5.4 hours. Seventy-four per cent of the participants were referred to physiotherapists, 24% to occupational therapists and none to social workers. Patient-reported outcome measures at baseline and 6 months indicated reduced anxiety, depression and pain and improved mental well-being, coping with fatigue, overall disease impact and quality of life. Conclusions: The INSELMA intervention is considered feasible and potentially effective in supporting patients with inflammatory arthritis by reducing disease impact and improving quality of life. Further testing in a larger randomised controlled trial is warranted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.